Brieflands
Journal finderSearch
·
Sign in

Journal of Reports in Pharmaceutical Sciences

e-ISSN 2322-5106
Home
Articles
    Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
About Journal
    Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Publication Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Announcement of New Publisher
Authors GuideSubmit manuscript
  1. Brieflands
  2. /
  3. journals
  4. /
  5. Journal of Reports in Pharmaceutical Sciences
  6. /
  7. Articles
  8. /
  9. Synthesis and Characterization of Hydrazide-Hydrazone Derivatives of 3-Pyridine Carboxylic Acid as Antimycobacterial Tuberculosis Agents
  10. /
  11. Scopus by Title (Ref)
Citation data

Scopus by Title (Ref)

Articles that cite the referenced work, matched by title from the Scopus database.

4 results·Updated October 09, 2026
← Back to article
1

Interaction of Copper(II) Complexes of Bidentate Benzaldehyde Nicotinic Acid Hydrazones with BSA: Spectrofluorimetric and Molecular Docking Approach

Acta Chimica Slovenica

2023

Zahirović A.

Open Access

2

Non-toxic Schiff bases as efficient corrosion inhibitors for mild steel in 1 M HCl: Electrochemical, AFM, FE-SEM and theoretical studies

Journal of Molecular Liquids

January 2018

Singh D.K.

3

4(N,N-dimethylamino) benzaldehyde nicotinic hydrazone as corrosion inhibitor for mild steel in 1 M HCl solution: An experimental and theoretical study

Journal of Molecular Liquids

1 April 2016

Singh D.K.

4

Antibacterial activities of novel nicotinic acid hydrazides and their conversion into N-acetyl-1,3,4-oxadiazoles Dedicated to Professor Abdel-Rahman S. Ferwanah on the occasion of his retirement

Bioorganic and Medicinal Chemistry Letters

15 December 2014

Morjan R.Y.

Need help?

Editorial, submission and technical questions all go to the same desk.

Submit a ticket
Brieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.